Apogee Therapeutics Newsroom

TD Cowen Maintains Apogee Therapeutics(APGE.US) With Buy Rating

Futu NewsDec 5 23:33

Promising Potential of Apogee Therapeutics: A Buy Rating Backed by Innovative Pipeline and Strategic Approach

TipRanksDec 5 23:29

TD Cowen Sticks to Its Buy Rating for Apogee Therapeutics, Inc. (APGE)

TipRanksDec 5 23:19

Apogee Therapeutics Analyst Ratings

BenzingaDec 4 00:33

CCORF Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $89

Futu NewsDec 3 20:33

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics, Inc. (APGE) and TransMedics Group (TMDX)

TipRanksDec 3 20:03

Wedbush Adjusts Price Target on Apogee Therapeutics to $90 From $87, Maintains Outperform Rating

MT NewswiresDec 2 20:01

Guggenheim Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Raises Target Price to $110

Futu NewsNov 27 20:33

CCORF Initiates Apogee Therapeutics(APGE.US) With Buy Rating, Announces Target Price $89

Futu NewsNov 25 19:33

Apogee Therapeutics Price Target Announced at $89.00/Share by Canaccord Genuity

Dow JonesNov 25 19:32

Apogee Therapeutics Initiated at Buy by Canaccord Genuity

Dow JonesNov 25 19:32

Apogee Therapeutics Analyst Ratings

BenzingaNov 25 19:23

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $100

Futu NewsNov 13 19:31

TD Cowen Maintains Apogee Therapeutics(APGE.US) With Buy Rating

Futu NewsNov 13 03:31

Promising Advancements and Strategic Positioning Propel Apogee Therapeutics, Inc. to a Buy Rating

TipRanksNov 13 02:37

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Raises Target Price to $100

Futu NewsOct 29 18:31

TD Cowen Maintains Apogee Therapeutics(APGE.US) With Buy Rating

Futu NewsOct 28 20:35

Apogee Therapeutics Price Target Maintained With a $87.00/Share by Wedbush

Dow JonesOct 25 23:19

Apogee Therapeutics Analyst Ratings

BenzingaOct 25 23:10

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $81

Futu NewsSep 30 18:31